Lund University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Lund University (LNU) is an educational service provider that offers master and bachelor programmes. It offers education and research in the areas of engineering, economics and management, science, law, social sciences, medicine, humanities, theology, fine art, music and others. The university spans its expertise in cancer research, neuroscience and neurodegenerative diseases, diabetes, stem cell therapy, epidemiology, Middle Eastern studies, materials science, and nanotechnology among others. It works in collaboration with other universities through international networks, cooperation platforms for research and education. LNU is headquartered in Lund, Sweden.

Lund University - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Lund University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Lund University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Lund University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Lund University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Lund University, Medical Devices Deals, 2012 to YTD 2018 10
Lund University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Lund University, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
RhoVac Enters into Research Agreement with Lund University 12
Rocket Pharma Entered into Research and Development Agreement with Lund University 13
Licensing Agreements 14
Novo Nordisk Enters into Research and Licensing Agreement with Lund University 14
Avrobio Enters into Licensing Agreement with Lund University 15
Equity Offering 16
Akuru Pharma Spin Out from Lund University 16
Lund University - Key Competitors 17
Lund University - Key Employees 18
Lund University - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 20
Recent Developments 21
Government and Public Interest 21
Oct 08, 2018: New discovery restores insulin cell function in type 2 diabetes 21
Oct 05, 2018: New function of a key component in the immune system discovered 24
Oct 05, 2018: Large grants awarded to research on brain repair and diatoms 25
Sep 26, 2018: Researchers devise new approach to target Alzheimers 27
Aug 29, 2018: Lund University research group receives follow-on DKK 1 million grant from Novo Nordisk Foundation for diabetes-related studies with Follicum peptides 28
Aug 22, 2018: New method grows brain cells from stem cells quickly and efficiently 29
Aug 21, 2018: Powerful molecules provide new findings about Huntingtons disease 31
Apr 18, 2018: Similarity between high-risk atherosclerotic plaque and cancer cells discovered 33
Apr 16, 2018: Hope for new treatment of severe epilepsy 34
Apr 09, 2018: Jan Sundquist at Lund University awarded an ERC Advanced Grant 35
Apr 06, 2018: Mechanism vital to keeping blood stem cells functional uncovered 36
Apr 03, 2018: Breakthrough for dangerous blood transfusion-related disease 37
Mar 02, 2018: Paradigm shift in the diagnosis of diabetes 38
Nov 30, 2017: Prestigious ERC grants awarded to Lund researchers 40
Nov 28, 2017: Molecular profiling of melanoma tumours explains differences in survival after T cell therapy 42
Nov 06, 2017: Helmsley Charitable Trust Awards $52 Million to Support the Global Platform for the Prevention of Autoimmune Diabetes 44
Nov 02, 2017: New research shows where in the brain the earliest signs of Alzheimers occur 46
Oct 25, 2017: New method helps rule out heart valve infection 48
Oct 05, 2017: Discovery of a new fusion gene class may affect the development of cancer 49
Sep 27, 2017: Grants to 18 research projects that may lead to future scientific breakthroughs 50
Jan 30, 2017: Unique mapping of methylome in insulin-producing islets 54
Product News 55
Jun 25, 2018: Fluorescent molecules reveal how cancer stem cells are selectively inhibited 55
May 29, 2017: New test method aims to predict allergenic potency of chemicals 56
Mar 12, 2018: New treatment for aggressive breast cancer 57
Mar 12, 2018: Aggressive breast cancer can be transformed into a treatable form 58
Other Significant Developments 59
Feb 06, 2017: An Innovative Medicines Initiative Project for Precision Medicine in DKD 59
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60

List Of Tables


Lund University, Pharmaceuticals & Healthcare, Key Facts 2
Lund University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Lund University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Lund University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Lund University, Deals By Therapy Area, 2012 to YTD 2018 9
Lund University, Medical Devices Deals, 2012 to YTD 2018 10
Lund University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
RhoVac Enters into Research Agreement with Lund University 12
Rocket Pharma Entered into Research and Development Agreement with Lund University 13
Novo Nordisk Enters into Research and Licensing Agreement with Lund University 14
Avrobio Enters into Licensing Agreement with Lund University 15
Akuru Pharma Spin Out from Lund University 16
Lund University, Key Competitors 17
Lund University, Key Employees 18
Lund University, Other Locations 19
Lund University, Subsidiaries 19
Lund University, Joint Venture 20

List Of Figures


Lund University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lund University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lund University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lund University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lund University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Lund University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Lund University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Lund University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Lund University, Medical Devices Deals, 2012 to YTD 2018 10

Lund University - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Lund University (LNU) is an educational service provider that offers master and bachelor programmes. It offers education and research in the areas of engineering, economics and management, science, law, social

USD 250 View Report

Lundin Petroleum AB (LUPE) - Oil and Gas - Deals and Alliances Profile

Lundin Petroleum AB (Lundin Petroleum) is an independent oil and gas exploration and production company that acquires, explores, develops and produces oil and gas properties in Norway. The company identifies

USD 250 View Report

Tulane University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tulane University (Tulane) is an educational service provider that provides biomedical courses and research programs. The university provides educational courses in the fields of architecture, business, law, liberal arts, medicine,

USD 250 View Report

Yonsei University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Yonsei University (Yonsei) is an educational university that offers higher education and research facilities. The university offers graduation programs in various areas such as applied statistics, architectural engineering, Asian studies

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available